A citation-based method for searching scientific literature


List of co-cited articles
962 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A restricted cell population propagates glioblastoma growth after chemotherapy.
Jian Chen, Yanjiao Li, Tzong-Shiue Yu, Renée M McKay, Dennis K Burns, Steven G Kernie, Luis F Parada. Nature 2012
1

Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
Cristiano Farace, Jaime Antonio Oliver, Consolacion Melguizo, Pablo Alvarez, Pasquale Bandiera, Ana Rosa Rama, Giulia Malaguarnera, Raul Ortiz, Roberto Madeddu, Jose Prados. PLoS One 2015
31
3

Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Meena Jhanwar-Uniyal, John V Wainwright, Avinash L Mohan, Michael E Tobias, Raj Murali, Chirag D Gandhi, Meic H Schmidt. Adv Biol Regul 2019
105
1

Biological Adaptations of Tumor Cells to Radiation Therapy.
Angeles Carlos-Reyes, Marcos A Muñiz-Lino, Susana Romero-Garcia, César López-Camarillo, Olga N Hernández-de la Cruz. Front Oncol 2021
3
33

The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors.
Diana Spiegelberg, Anja C Mortensen, Sara Lundsten, Christopher J Brown, David P Lane, Marika Nestor. Cancer Res 2018
21
4

Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5.
Jingli Wang, Chris P Guise, Gabi U Dachs, Yen Phung, Annie Huai-Ling Hsu, Neil K Lambie, Adam V Patterson, William R Wilson. Biochem Pharmacol 2014
25
4

The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression.
Guang Lei, Yilei Zhang, Pranavi Koppula, Xiaoguang Liu, Jie Zhang, Steven H Lin, Jaffer A Ajani, Qin Xiao, Zhongxing Liao, Hui Wang,[...]. Cell Res 2020
254
1

Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.
Geert O Janssens, Saskia E Rademakers, Chris H Terhaard, Patricia A Doornaert, Hendrik P Bijl, Piet van den Ende, Alim Chin, Henri A Marres, Remco de Bree, Albert J van der Kogel,[...]. J Clin Oncol 2012
181
1

Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.
M M Fitzek, A F Thornton, J D Rabinov, M H Lev, F S Pardo, J E Munzenrider, P Okunieff, M Bussière, I Braun, F H Hochberg,[...]. J Neurosurg 1999
159
1

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma.
David A Reardon, Louis B Nabors, Warren P Mason, James R Perry, William Shapiro, Petr Kavan, David Mathieu, Surasak Phuphanich, Agnieszka Cseh, Yali Fu,[...]. Neuro Oncol 2015
105
1

Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
Anaelle A Dumas, Nicola Pomella, Gabriel Rosser, Loredana Guglielmi, Claire Vinel, Thomas O Millner, Jeremy Rees, Natasha Aley, Denise Sheer, Jun Wei,[...]. EMBO J 2020
35
2

A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
Andra V Krauze, Sten D Myrehaug, Michael G Chang, Diane J Holdford, Sharon Smith, Joanna Shih, Philip J Tofilon, Howard A Fine, Kevin Camphausen. Int J Radiat Oncol Biol Phys 2015
119
1

Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials.
Haley K Perlow, Rahul N Prasad, Mike Yang, Brett Klamer, Jennifer Matsui, Livia Marrazzo, Beatrice Detti, Marta Scorsetti, Elena Clerici, Andrea Arnett,[...]. Cancer 2022
1
100

High-dose single-fraction radiotherapy: exploiting a new biology?
J Martin Brown, Albert C Koong. Int J Radiat Oncol Biol Phys 2008
79
1

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.
Michael H Kershaw, Jennifer A Westwood, Linda L Parker, Gang Wang, Zelig Eshhar, Sharon A Mavroukakis, Donald E White, John R Wunderlich, Silvana Canevari, Linda Rogers-Freezer,[...]. Clin Cancer Res 2006
820
1

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms.
Arnab Chakravarti, Michael G Erkkinen, Ulf Nestler, Roger Stupp, Minesh Mehta, Ken Aldape, Mark R Gilbert, Peter McL Black, Jay S Loeffler. Clin Cancer Res 2006
160
1

Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study.
Alessandra Fabi, Alessandra Mirri, Alessandra Felici, Antonello Vidiri, Andrea Pace, Emanuele Occhipinti, Francesco Cognetti, Giorgio Arcangeli, Bruno Iandolo, Maria Antonia Carosi,[...]. J Neurooncol 2008
12
8

Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer.
J Sigmond, R J Honeywell, T J Postma, C M F Dirven, S M de Lange, K van der Born, A C Laan, J C A Baayen, C J Van Groeningen, A M Bergman,[...]. Ann Oncol 2009
50
2

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.
Kathryn E O'Reilly, Fredi Rojo, Qing-Bai She, David Solit, Gordon B Mills, Debra Smith, Heidi Lane, Francesco Hofmann, Daniel J Hicklin, Dale L Ludwig,[...]. Cancer Res 2006
1

Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine).
B Lund, P E Kristjansen, H H Hansen. Cancer Treat Rev 1993
135
1


Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro.
Vasiliki Zoi, Vasiliki Galani, Evrysthenis Vartholomatos, Natalia Zacharopoulou, Eftichia Tsoumeleka, Georgios Gkizas, Georgios Bozios, Pericles Tsekeris, Ieremias Chousidis, Ioannis Leonardos,[...]. Biomedicines 2021
7
14

CD70, a novel target of CAR T-cell therapy for gliomas.
Linchun Jin, Haitao Ge, Yu Long, Changlin Yang, Yifan Emily Chang, Luyan Mu, Elias J Sayour, Gabriel De Leon, Qiong J Wang, James C Yang,[...]. Neuro Oncol 2018
75
1



Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase.
Ross Carruthers, Shafiq U Ahmed, Karen Strathdee, Natividad Gomez-Roman, Evelyn Amoah-Buahin, Colin Watts, Anthony J Chalmers. Mol Oncol 2015
82
1

Gemcitabine-mediated radiosensitization.
T S Lawrence, A Eisbruch, D S Shewach. Semin Oncol 1997
87
1

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.
Stephanie E Combs, Christoph Thilmann, Lutz Edler, Jürgen Debus, Daniela Schulz-Ertner. J Clin Oncol 2005
223
1

Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
Nicholas Brown, Catherine McBain, Stephen Nash, Kirsten Hopkins, Paul Sanghera, Frank Saran, Mark Phillips, Fiona Dungey, Laura Clifton-Hadley, Katharina Wanek,[...]. PLoS One 2016
29
3

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Shideng Bao, Qiulian Wu, Roger E McLendon, Yueling Hao, Qing Shi, Anita B Hjelmeland, Mark W Dewhirst, Darell D Bigner, Jeremy N Rich. Nature 2006
1

Biological effects of hydrogen peroxide administered intratumorally with or without irradiation in murine tumors.
Taiki Takaoka, Yuta Shibamoto, Masayuki Matsuo, Chikao Sugie, Taro Murai, Yasutaka Ogawa, Akifumi Miyakawa, Yoshihiko Manabe, Takuhito Kondo, Koichiro Nakajima,[...]. Cancer Sci 2017
12
8

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
Stephen T Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G Trinidad, Jacqueline H L Fok,[...]. Sci Adv 2018
113
1

Plasma membrane signaling induced by ionizing radiation.
Isabelle Corre, Colin Niaudet, Francois Paris. Mutat Res 2010
81
1

Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells.
Ravi D Rao, Ann C Mladek, Jeffrey D Lamont, Jennie M Goble, Charles Erlichman, C David James, Jann N Sarkaria. Neoplasia 2005
85
1


Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors.
R Rampling, G Cruickshank, A D Lewis, S A Fitzsimmons, P Workman. Int J Radiat Oncol Biol Phys 1994
244
1

Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro.
D Latz, K Fleckenstein, M Eble, J Blatter, M Wannenmacher, K J Weber. Int J Radiat Oncol Biol Phys 1998
98
1

p53 dynamics vary between tissues and are linked with radiation sensitivity.
Jacob Stewart-Ornstein, Yoshiko Iwamoto, Miles A Miller, Mark A Prytyskach, Stephane Ferretti, Philipp Holzer, Joerg Kallen, Pascal Furet, Ashwini Jambhekar, William C Forrester,[...]. Nat Commun 2021
10
10

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, Wenting Wu, Kurt A Jaeckle, Joon H Uhm, Francois J Geoffroy, Robert Arusell, Gaspar Kitange, Robert B Jenkins,[...]. J Clin Oncol 2008
196
1

RRx-001, A novel dinitroazetidine radiosensitizer.
Bryan Oronsky, Jan Scicinski, Shoucheng Ning, Donna Peehl, Arnold Oronsky, Pedro Cabrales, Mark Bednarski, Susan Knox. Invest New Drugs 2016
21
4

Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation.
H Machida, Y Matsumoto, M Shirai, N Kubota. Int J Radiat Biol 2003
58
1


Heterogeneity of tumor-induced gene expression changes in the human metabolic network.
Jie Hu, Jason W Locasale, Jason H Bielas, Jacintha O'Sullivan, Kieran Sheahan, Lewis C Cantley, Matthew G Vander Heiden, Dennis Vitkup. Nat Biotechnol 2013
273
1

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma.
Xuejiao Liu, Xiangyu Chen, Lin Shi, Qianqian Shan, Qiyu Cao, Chenglong Yue, Huan Li, Shengsheng Li, Jie Wang, Shangfeng Gao,[...]. J Exp Clin Cancer Res 2019
45
2


Electron affinic sensitization. II. Para-nitroacetophenone: a radiosensitizer for anoxic bacterial and mammalian cells.
G E Adams, J C Asquith, D L Dewey, J L Foster, B D Michael, R L Willson. Int J Radiat Biol Relat Stud Phys Chem Med 1971
104
1

Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Meena Jhanwar-Uniyal, John L Gillick, Jayson Neil, Michael Tobias, Zachary E Thwing, Raj Murali. Adv Biol Regul 2015
52
1

Erlotinib: an EGF receptor tyrosine kinase inhibitor in non-small-cell lung cancer treatment.
Clorinda Schettino, Maria Anna Bareschino, Vincenzo Ricci, Fortunato Ciardiello. Expert Rev Respir Med 2008
37
2


Tumor treating fields: a new frontier in cancer therapy.
Angela M Davies, Uri Weinberg, Yoram Palti. Ann N Y Acad Sci 2013
88
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.